• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Author
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Author "丁小燕" 24 results
        • 息肉樣脈絡膜血管病變與滲出型老年性黃斑變性的異同

          息肉樣脈絡膜血管病變(PCV)是一種好發于有色人種,以脈絡膜異常分支狀血管網及其末端的息肉樣擴張病灶為特點,伴有反復漿液性或出血性視網膜色素上皮脫離(PED)的黃斑部血管疾病。PCV與滲出型老年性黃斑變性中經典型脈絡膜新生血管病灶之間有很多共性,均可表現為出血、滲出、漿液性或出血性PED;遺傳學研究也顯示有一些共同的遺傳背景。但兩者也有很多不同點,如吲哚青綠血管造影和光相干斷層掃描檢查表現相去甚遠;對光動力療法和抗血管內皮生長因子治療的反應也有所不同。兩者到底是同一種疾病的不同亞型,還是兩種獨立疾病值得進一步深入探討。了解其流行病學、臨床特征、組織學特征、影像學表現及其治療等方面的異同,在此基礎上制定統一的PCV分類方法,深入研究PCV在東方人群中高發的危險因素及發病機制,確定PCV最佳治療方案是今后的研究方向。

          Release date:2016-09-02 05:26 Export PDF Favorites Scan
        • Understanding the characteristics of myopic choroidal neovascularization to improve its diagnosis and treatment outcome and follow-up strategy

          Myopic choroidal neovascularization (MCNV) is one of the main reasons of vision loss in working population in Asia, which has brought economical and social-psychological burdens with high incidence in China, The precise pathogenesis of MCNV is unclear. Metamorphosia is the main reported symptom in these patients. The lesions were usually with smaller area, less leakage and relatively slow progression. Currently, intravitreal anti-vascular endothelial growth factor agents are now the established standard of care for MCNV, which was a major breakthrough in the treatment of MCNV achieving visual acuity improvement. Since the natural history, clinical features and therapy response of this disease is significant different from that in choroidal neovascularization secondary to age-related macular degeneration, the treatment dosing, frequency, retreatment criteria and the follow-up interval should been considerately. Facing the myopia boom in China, there is a need for the development of a precise definition and a more detailed classification for pathogenic myopia, optimize the outcome assessment and follow-up strategy, which should benefit to the further basically and clinical studies.

          Release date:2017-11-20 02:25 Export PDF Favorites Scan
        • 微創玻璃體切割手術后眼內炎

          微創玻璃體切割手術后眼內炎是發生在微創玻璃體視網膜手術后早期出現的感染性眼內炎。鞏膜穿刺裂口不閉、低眼壓、無眼內填充物、免疫抑制、手術后局部糖皮質激素使用、玻璃體束綜合征、手術前準備不足、手術中輔助用藥和手術時間長等為其相關的危險因素。致病菌以表皮葡萄球菌及凝固酶陰性葡萄球菌為主。藥物治療目前多選萬古霉素和頭孢他啶聯合用藥; 但這兩種藥物將有可能被利奈唑胺和替考拉寧逐漸取代。再次行玻璃體切割手術是其主要治療手段。聚維酮碘、眼內灌注液手術前和手術中的合理使用在預防其發生方面有一定作用。

          Release date: Export PDF Favorites Scan
        • Choroidal neovascularization secondary to pathologic myopia:a recent update on diagnosis and treatment

          Pathological myopia can induce choroidal neovascularization (PM-CNV). The potential risk factors include ageing, long axial length of the eyeball, thinning of subfoveal choroidal thickness, fundus atrophy spot and lacquer crack. These factors may induce atrophy of retinal pigment epithelial cells (RPE) and hypoxia, resulting in vascular endothelial growth factors (VEGF) secretion by outer retina. The lesion type, location and activity of PM-CNV can be determined by fundus fluorescein angiography. The features of PM-CNV on optical coherence tomography include strong reflective area close to RPE with very small amount of subretinal fluid (active stage), surface strong reflection with signal attenuation area (scar stage) and flat lesion and chorioretinal atrophy (atrophy stage). Photodynamic therapy and intravitreal injection of anti-VEGF drugs are major treatments for PM-CNV, the latter is more commonly used now. However, more large randomized controlled studies are required to explore the treatment regimen (such as frequency, indications for repeated or termination of treatment) and the efficacy factors further.

          Release date: Export PDF Favorites Scan
        • Observation of clinical characteristics and surgical outcomes of retinal detachment associated with atopic dermatitis

          ObjectiveTo observe the clinical characteristics and surgical outcomes in patients with retinal detachment associated with atopic dermatitis (AD-RD). MethodsA retrospective case series. From January 2015 to April 2023, 8 patients (12 eyes) with AD-RD at Zhongshan Ophthalmic Center of Sun Yat-sen University were included. All patients underwent best-corrected visual acuity (BCVA), ultra-wide-field fundus photography, B-mode ultrasound, ultrasound biomicroscopy (UBM), and wide-field optical coherence tomography (OCT). BCVA was examined by standard logarithmic visual acuity chart and was converted into logarithm of the minimum angle of resolution (logMAR) visual acuity for statistical purposes. In the primary surgery, 9 eyes underwent scleral buckling; 1 eye underwent pars plana vitrectomy (PPV) combined with silicone oil tamponade; 1 eye underwent PPV combined with C3F8 tamponade; 1 eye underwent C3F8 tamponade combined with retinal laser photocoagulation. The follow-up time was (29.1±40.9) months. BCVA before and after surgery was compared using paired t test. ResultsAmong the 8 patients, 6 were male and 2 were female. The mean age was (23.38±7.95) years old. Among them, 4 patients had bilateral affliction while the remaining 4 had unilateral involvement. The logMAR BCVA was 0.86±0.86. All 12 eyes were with a history of uveitis. Among 8 eyes with bilateral involvement, 6 of them were misdiagnosed as uveitis with exudative retinal detachment; 11 eyes had anterior uveitis at presentation; 9 eyes had a history of cataract, with 4 eyes having concurrent cataract and 5 eyes with intraocular lens. All affected eyes displayed as focal retinal detachment. UBM revealed ciliary epithelial detachment in 9 eyes, and no definite ciliary epithelial break was found in any case. Retinal breaks were observed in only 2 eyes in the pre-surgery retina examination, while ciliary epithelial holes were discovered in other 10 eyes during surgery. The retina was successfully reattached in 10 eyes after one surgery, including 9 eyes received scleral buckling. During the final follow-up, the logMAR BCVA of the affected eye improved significantly to 0.30±0.25 compared to pre-surgery values (t=2.43, P=0.03). ConclusionsAD-RD is a challenging complication of AD with a high rate of young onset, bilateral involvement, associated with concurrent cataracts, and shallow temporal retinal detachment associated with ciliary epithelial detachment. Scleral buckling is an effective treatment for AD-RD.

          Release date:2023-12-27 08:53 Export PDF Favorites Scan
        • Choroidal thickness and the correlation factor in myopic Chinese population

          Objective To measure the choroidal thickness (CT) in myopic Chinese population and to analyze the correlation factors. Methods One hundred and thirty-four myopia patients (268 eyes) were recruited in this study, including 88 males and 46 females. Ages were from 18 to 38 years, with a mean of (21.5±4.3) years. The spherical equivalent power was -13.13 to -0.50 D, with a mean of (-5.17±2.15) D. The choroid thickness (CT) in macular region was measured by spectral-domain optical coherence tomography. The CT values at subfoveal (SFCT), 1 mm temporal (T1 mm), nasal (N1 mm), superior (S1 mm) and inferior (I1 mm) to the fovea and 3 mm temporal (T3 mm), nasal (T3 mm), superior (S3 mm) and inferior (I3 mm) to the fovea were recorded respectively. The correlation between SFCT and age, uncorrected vision (VAsc), best corrected visual acuity (BCVA), equivalent power, corneal curvature, central corneal thickness and axial length were analyzed. Vision results were converted into logarithm of minimal angle resolution (1ogMAR) so as to analyze statistically. Results The mean SFCT were (230.4±70.2) μm in this study. The SFCT was statistically different from the CT at S1 mm, I1 mm, T1 mm, N1 mm, S3 mm, T3 mm, N3 mm(t=4.279, 2.256, -7.498, 19.020, 7.286, -5.752, 37.921; P<0.05) respectively, except the CT at I3 mm(t=0.695, P>0.05). There was a positive correlation between SFCT and equivalent power (r=0.251, P<0.05), corneal curvature (r=0.194, P<0.05). The SFCT was negatively correlated with 1ogMAR VAsc (r=-0.279, P<0.05) and axial length (r=-0.367,P<0v05). No correlation was found between SFCT and age, 1ogMAR BCVA and central corneal thickness(r=-0.047, -0.091, -0.068; P>0.05). Conclusions The SFCT in Chinese myopic subjects is (230.4±70.2) μm. SFCT is correlated with VAsc, equivalent power, corneal curvature and axial length. The axial length is the key factor affecting SFCT.

          Release date:2016-09-02 05:22 Export PDF Favorites Scan
        • 新生兒視網膜出血

          新生兒視網膜出血(RH)是指新生兒在出生1個月內發生的RH。其發生可能與分娩方式、孕母患病及胎兒疾病等因素有關。經陰道分娩引起的胎頭受壓以及胎頭急速下降引起的壓力急劇變化可能是其發生的重要原因。多表現為雙眼出血。出血常位于視網膜后極部,以淺層出血為主。出血形態可以是點狀、線狀及火焰狀。通常病情較輕,預后較好,出血可于2周內完全吸收,目前認為尚無需治療。少數嚴重出血或黃斑、玻璃體積血吸收緩慢,可能影響患兒視功能發育,導致弱視發生。對新生兒RH與兒童弱視之間的關系、新生兒RH是否需要干預以及如何干預,是今后新生兒RH研究的方向。

          Release date: Export PDF Favorites Scan
        • An update on anti-vascular endothelial growth factor therapy in retinal diseases

          Vascular endothelial growth factor (VEGF) is a multifunctional factor that promotes blood vessel formation and increases vascular permeability. Its abnormal elevation plays a key role in common retinal diseases such as wet age-related macular degeneration and diabetic macular edema. Anti-VEGF therapy can inhibit angiogenesis, reduce vascular leakage and edema, thereby delaying disease progression and stabilizing or improving vision. Currently, the clinical application of anti-VEGF drugs has achieved satisfactory therapeutic effects, but there are also issues such as high injection frequency, heavy economy burden, potential systemic side effects, and non-responsiveness. To address these issues, current research and development mainly aim on biosimilars, multi-target drugs, drug delivery systems, oral anti-VEGF drugs, and gene therapy. Some drugs have shown great potential and are expected to turn over a new leaf for anti-VEGF treatment in ophthalmology.

          Release date:2023-09-12 09:11 Export PDF Favorites Scan
        • Preliminary report of arteriovenous sheathotomy for treatment of branch retinal vein occlusion

          Objective lt;brgt;To evaluate the efficacy of arteriovenous sheathotomy on treatment of branch retinal vein occlusion (BRVO). lt;brgt; lt;brgt;Methods lt;brgt;Six consecutive patients (6 eyes) with BRVO underwent par plana vitrectomy, po lt;brgt;sterios vitreous cortex separation, arteriovenous sheathotomy for BRVO. The foll lt;brgt;owup period was within 3~12 months. Postoperative examinations included color fundus photography, fundus fluorescein angiography(FFA), optical coherence tomography(OCT) and multifocal electroretinography (mERG). lt;brgt; lt;brgt;Results lt;brgt;Increasing downstream blood flow in proximal past of compressed venule was promptly observed during the procedures of incision of the advential sheath of blood vessel, and separating and elevating the ateriole from the venule in all the operations in this series. Visual acuities improved postoperatively in 5 patients, and the best corrected visual acuity was 1.5. The examination of FFA showed obvious absorption of retinal hemorrhage, and leakage of dye was reduced, while large areas of capillary closure in retinas distal to the sheathotomy site were found 3 months after operation in 3 patients. OCT revealed disappearance or lightening of macular edema. mERG showed that the response amplitude of retina including the macular area was obviously higher after the operation. There was recurrent vitreous hemorrhage necessitating further surgery in one patient. lt;brgt; lt;brgt;Conclusion lt;brgt;The operation of arteriovenous sheathotomy for the treatment of BRVO is much beneficial to improve patient′s visual acuity, downstream blood flow and macular affections, although the improvement of retinal reperfusion of the retina is not obvious. lt;brgt; lt;brgt;(Chin J Ocul Fundus Dis,2002,18:6-9)

          Release date:2016-09-02 06:01 Export PDF Favorites Scan
        • Enhancing the research on the mechanism of the occurrence and development of retinal neovascularization to prevent and treat retinal neovascularization diseases

          Retinal neovascularization is a complicated pathophysiological process as a result of imbalance between angiogenic and antiangiogenic factors. Correct understanding of the signaling pathways, exploring the critical factors involved in retinal angiogenesis, looking for new strategies by reconstructing the new vessels are helpful for knowing the mechanism of the occurrence and development of reitnal neovascularization, which would be good for preventing and treating retinal neovascularization diseases.

          Release date:2016-09-02 05:41 Export PDF Favorites Scan
        3 pages Previous 1 2 3 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜